01/07/2026
KinExA in the Era of AI and Biologics Innovation:
Accurate affinity and kinetics data are critical in modern drug discovery, especially as biologics become more specific and tightly binding. Traditional biosensors often fall short, but KinExA offers femtomolar precision and reproducibility. This presentation explores KinExA’s advantages in workflows enhanced by AI-based antibody design, NGS, and novel formats like virus-like particles.